| Global collaboration agreement with Simbionix |
| Thursday, April 16, 2009 |
|
VirtaMed and Simbionix join forces to distribute VirtaMed HystSim™ world-wide
We proudly announce that VirtaMed and Simbionix have joined forces to distribute VirtaMed HystSim™ world-wide. Simbionix is the world’s leading developer of medical simulation systems and already offers a wide spectrum of simulators for minimally invasive surgery. VirtaMed HystSim™ will be distributed exclusively and world-wide by Simbionix. Additional information can be found at the Simbionix HystSim website. Official press release: Simbionix Increases Product Offerings for OB/GYN Physicians Simbionix and VirtaMed have joined forces to provide OB/GYN surgeons the most advanced training system for endoscopic surgery. The new VirtaMed HystSim™ simulator adds hysteroscopy to Simbionix’ impressive line of medical simulation and eLearning products.
March 12, 2009, Cleveland, OH, USA and Zurich, Switzerland: Simbionix, the world’s leading developer of medical simulation systems, and VirtaMed, a Swiss medical engineering company, announced today a global collaboration agreement. Simbionix will exclusively distribute, market, and provide service for the VirtaMed HystSim™, an advanced virtual reality hysteroscopy simulator. Simbionix already offers a wide spectrum of simulators for minimal invasive surgery. “This new agreement further expands our product offering,” says Simbionix CEO Gary Zamler. “The addition of the HystSim simulator, along with our recently launched laparoscopic surgery module for gynecology, shows how seriously Simbionix is investing in women’s healthcare issues". Simbionix’ President and founder, Mr. Ran Bronstein, adds: “our simulation technology is definitely a revolution in the world of medical training and assessment. We are happy to be working together with VirtaMed, a company as committed to technology and simulation quality as we are. Simbionix will keep increasing its product offering to the medical community and bring quality and service to its customers and partners”. "VirtaMed is thrilled to be working together with Simbionix, the market leader in surgical simulation," adds VirtaMed CEO Stefan Tuchschmid. "Simbionix is a partner that will ensure the HystSim simulator is available globally. We truly appreciate Simbionix' commitment to provide the best possible training for surgeons in every field.” VirtaMed HystSim™ will be officially launched at the next ACOG (American College of Obstetricians and Gynecologists) annual clinical meeting held in Chicago on May 2nd. About VirtaMed
About Simbionix |